Back to trial details

Intake questionnaire

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

Applying to The University of Chicago · Chicago, Illinois

Answer a few short questions to share with the research team.

0 of 2 answered

1. Have you been diagnosed with Parenteral Nutrition Associated Liver Disease (PNALD)?
2. Are you able to travel to Chicago for study visits?